Home Analyst Ratings

Analyst Ratings

Random

Analyst Upgrades – BJ's Restaurants (NASDAQ:BJRI) Stock Gets Upgraded By Wedbush from Neutral to Outperform

ME Staff - February 15, 2018

Analyst Upgrades – Lennar (NYSE:LEN) Stock Gets Upgraded By Evercore ISI from In-Line to Outperform

Analyst Activity – Canaccord Genuity Lowers Its Price Target On Utilitywise PLC (LON:UTW) to GBX 100

Analyst Upgrades – SMLP – Summit Midstream (NYSE:SMLP) Stock Gets Upgraded By US Capital Advisors from Sell to Hold

Analyst Downgrades – China Telecom (NYSE:CHA) Stock Gets Downgraded By Nomura from Buy to Neutral

Analyst Activity – Needham & Company LLC Raises Its Price Target...

ME Staff - January 26, 2018

Analyst Downgrades – Edge Therapeutics (NASDAQ:EDGE) (NASDAQ:EDGE) Stock Gets Downgraded By...

ME Staff - March 28, 2018

Analyst Activity – Craig Hallum Initiates Coverage On NASDAQ:LAZY – Andina...

ME Staff - April 10, 2018

Analyst Activity – Morgan Stanley Raises Its Price Target On Cognizant...

ME Staff - February 5, 2018

Analyst Activity – JPMorgan Chase & Co. Lowers Its Price Target...

ME Staff - February 14, 2018

Analyst Activity – Citigroup Inc. Lowers Its Price Target On Chesapeake...

ME Staff - July 21, 2017

Analyst Activity – Berenberg Bank Initiates Coverage On Hollywood Bowl Group...

ME Staff - July 19, 2017

Analyst Upgrades – Express Scripts (NASDAQ:ESRX) Stock Gets Upgraded By Sanford...

ME Staff - March 12, 2018

Analyst Activity – Seaport Global Securities Reiterates Buy on NYSE:ARNC –...

ME Staff - April 19, 2018

Analyst Activity – Scotiabank Reiterates Hold on Apache Corporation (NYSE:APA)

ME Staff - October 10, 2017

12 3...1,256 Page 1 of 1,256

EDITOR PICKS

Market Exclusive Daily Roundup, What You Need To Know April 18

April 18, 2018

Here’s What Happened Last Week In Biotech

April 17, 2018

ArQule, Inc. Is Moving On ASCO Release, Here’s Why.

April 16, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.